Osteoporosis Treatment Under COVID-19

June 19, 2020

A steering committee of the American Society for Bone Mineral Research recently issued COVID-19 treatment guidelines for patients receiving osteoporosis treatments. In this interview, E. Michael Lewiecki, M.D., director of the New Mexico Clinical Research and Osteoporosis Center and a University of New Mexico program called Bone Health TeleECHO, shares his best practices for treating osteoporosis patients during the pandemic.

The Pros and Cons of DXA-What Are the Alternatives?

June 10, 2020

A wide range of techniques are used in research to assess bone density and quality, but dual-energy X-ray absorptiometry (DXA) is likely to remain the standard procedure used in clinical practice for the foreseeable future for most patients, predicts the co-author of a recent review of imaging-based techniques for assessing bone in rheumatology.

Managing Osteoporosis in the Era of COVID-19

June 10, 2020

COVID-19 is delaying and disrupting the treatment of many patients with osteoporosis, so the American Society for Bone and Mineral Research (ASBMR) set up a steering committee of bone specialists to consider how best to manage these patients.

Do bisphosphonates cause atrial fibrillation?

May 20, 2020

In this interview with Dr. Kamalan Jeevaratnam, a cardiac electrophysiologist with the Faculty of Health and Medical Sciences at the University of Surrey, we explore whether bisphosphonates are associated with atrial fibrillation. “There are a group of studies that show bisphosphonates are proarrhythmic and a group that show they do not cause any problem,” he said in this interview with Rheumatology Network from his home in London.

High Platelet Counts Associated With Osteopenia and Osteoporosis

May 06, 2020

High platelet levels within the normal range might be an early indicator for increased risk of osteoporosis, study suggests.

Examining the Risk Between Atrial Fibrillation and Bisphosphonates

May 05, 2020

The jury is still out on whether there is a link between the use of bisphosphonates and an increased risk of atrial fibrillation, but doctors prescribing the drugs should bear in mind there may be a link, says the authors of a recent review published online in the Annals of the New York Academy of Sciences.

Osteoporosis Treatments Feared and Underused

April 21, 2020

Despite an apparent and increasing need for osteoporosis treatments, fewer people today are taking the medications both here in the United States and abroad.

The Side Effects of Osteoporosis Treatments

April 21, 2020

In this slideshow, we highlight new data on side effects associated with osteoporosis treatments. The data show that side effects previously thought of as common, are actually rare. 

Guideline Update: Romosozumab in Osteoporosis

March 31, 2020

New treatment guidelines for osteoporosis from the Endocrine Society now include romosozumab for postmenopausal women with severe osteoporosis. Learn more in this report.

Biologics Help Maintain Bone Density in RA

February 28, 2020

Bone mineral density was preserved over a three-year period in patients with rheumatoid arthritis treated with biological/targeted synthetic disease-modifying antirheumatic drugs (DMARDS) but declined in those who received only conventional-synthetic DMARDs, say researchers recently writing in Rheumatology.